At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets
The DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.
Abstract
Tumor-associated macrophages (TAM) constitute a prominent immune cell population within various solid cancers, playing a pivotal role in disease progression. Their increased numbers and frequencies often strongly correlate with resistance to therapy and reduced overall survival rates. Within the complex ecosystem of the tumor microenvironment (TME), activated cancer-associated fibroblasts (CAF) are expanded and contribute significantly to tumor growth and metastasis and chemotherapy or immunotherapy resistance. CAFs exert a critical influence on TAM phenotypes and functions by orchestrating the reprogramming of tissue-infiltrating monocytes, thereby modulating their survival and differentiation. This reciprocal interaction between TAMs and CAFs forms a crucial axis in fostering a suppressive crosstalk within the TME, mediated by a diverse array of signals exchanged between these cell types. Recent advancements in single-cell RNA sequencing technologies and spatial transcriptomics have enhanced our comprehension of the signaling dynamics at the interface between TAMs and CAFs, including their spatial distribution within the tissue. In this review, we delve into the latest discoveries elucidating the biology of TAM and CAF crosstalk. We examine the complexity of TAM–CAF and CAF–TAM interactions within the TME of solid cancers, with particular focus on ligand–receptor interactions and clinically significant targets for novel therapeutic strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in pancreatic cancer, TAMs and CAFs collaborate to create a dense stromal barrier that limits T cell infiltration and drug delivery (Timperi et al., 2024).”
From Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review (2026) · cites this paper as Timperi et al., 2024
In the citing paper
“CAFs secrete chemokines and growth factors that recruit and polarize TAMs toward an immunosuppressive phenotype (Timperi et al., 2024).”
From Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review (2026) · cites this paper as Timperi et al., 2024
In the citing paper
“For instance, CAFs produce CCL2, which attracts monocytes that differentiate into TAMs, while TAMs secrete TGF-β to activate CAFs, creating a positive feedback loop (Timperi et al., 2024).”
From Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review (2026) · cites this paper as Timperi et al., 2024
In the citing paper
“Single-cell RNA sequencing (scRNA-seq) has revealed that this crosstalk is spatially regulated, with specific ligand-receptor interactions occurring at the interface between TAMs and CAFs (Timperi et al., 2024).”
From Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review (2026) · cites this paper as Timperi et al., 2024
Citations
Cites
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Elyada, E., Bolisetty, M., Laise, P., Flynn, W. F., Courtois, E. T., Burkhart, R. A., Teinor, J. A., Belleau, P., Biffi, G., Lucito, M. S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0094 · Cited by 2,241
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Azizi, E., Carr, A. J., Plitas, G., Cornish, A. E., Konopacki, C., Prabhakaran, S., Nainys, J., Wu, K., Kiseliovas, V., Setty, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.060 · Cited by 1,976
Böttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
Macrophages as tools and targets in cancer therapy
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00520-5 · Cited by 1,807
A single-cell and spatially resolved atlas of human breast cancers
Wu, S. Z., Al-Eryani, G., Roden, D. L., Junankar, S., Harvey, K., Andersson, A., Thennavan, A., Wang, C., Torpy, J. R., Bartonicek, N., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00911-1 · Cited by 1,775
Research works printed but not linked: 1
- Nagano, 2021, CD204-positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand-1 expression, Oncol Lett, 21, 36
Cited by
Li, Y., You, J., Zou, Z., Sun, G., Shi, Y., Sun, Y., Xu, S., & Zhang, X. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.114222 · Cited by 54
Liu, F., Li, X., Zhang, Y., Ge, S., Shi, Z., Liu, Q., & Jiang, S. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03490-9 · Cited by 54
SPP1+ macrophages in tumor immunosuppression: mechanisms and therapeutic implications
Wang, J., Wang, Y., Liu, Y., & Yang, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1711015 · Cited by 46
Tian, Z., Cen, L., Feng, W., Dong, J., Huang, Y., Han, Y., Wang, Z., Deng, J., & Jiang, Y. (2025) · Oncology Letters · doi:10.3892/ol.2025.15121 · Cited by 40
Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy
Coelho, R. M. L., Debets, R., & Hammerl, D. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02481-w · Cited by 37
Metadata
- Authors
- Timperi, E., Croizer, H., Khantakova, D., Rana, M., Molgora, M., Guerriero, J. L., Mechta-Grigoriou, F., & Romano, E.
- Affiliations
- Fondazione Santa Lucia (IT)
- Inserm (FR)
- Washington University in St. Louis (US)
- 2Institut Curie, Stress and Cancer Laboratory, Équipe Labélisée par la Ligue Nationale Contre le Cancer, PSL Research University, Paris, France.
- Moffitt Cancer Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Romano, Emanuela
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2024-09-23
- Volume
- 30
- Issue
- 23
- Pages
- 5242-5251
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W4402731724
- Cited by
- 49
- References
- 120
- Citations by year
- 2026: 29 · 2025: 20
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor-associated macrophages, cancer-associated fibroblasts, tumor microenvironment, immunosuppression, monocyte reprogramming, ligand-receptor interactions, therapeutic target, chemoresistance, immunotherapy resistance, metastasis, solid tumors
- MeSH terms
- Cancer-Associated Fibroblasts, Tumor-Associated Macrophages, Animals, Cell Communication, Humans, Neoplasms, Signal Transduction, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-24-1690
- The paper
- Timperi, E., Croizer, H., Khantakova, D., Rana, M., Molgora, M., Guerriero, J. L., Mechta-Grigoriou, F., & Romano, E. (2024). At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-1690
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.